Mpox in Pregnancy - Risks, Vertical Transmission, Prevention, and Treatment

Jean B Nachega¹, Emma L Mohr¹, Pradip Dashraath¹+8

• ¹From the Departments of Epidemiology, Infectious Diseases, and Microbiology, University of Pittsburgh School of Medicine, Pittsburgh (J.B.N.); the Departments of Epidemiology and International Health, Johns Hopkins Bloomberg School of Public Health (J.B.N.), and the Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine (J.R.A.) - both in Baltimore; the Department of Medicine, Division of Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences (J.B.N.), and the Division of Epidemiology and Biostatistics, School of Public Health, University of Cape Town (L.M.) - both in Cape Town, South Africa; the Department of Pediatrics, University of Wisconsin-Madison, Madison (E.L.M.); the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, National University Hospital, Singapore City, Singapore (P.D.); the Institut National de Recherche Biomédicale (INRB) and the Departments of Microbiology and Virology, University of Kinshasa School of Medicine - both in Kinshasa, Democratic Republic of Congo (P.M.-K., J.-J.M.-T.); the Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco (M.G.); Materno-fetal and Obstetrics Research Unit, Department "Femme-Mère-Enfant," Lausanne University Hospital, and University of Lausanne, Lausanne, Switzerland (D.B.); and the Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC (L.L.M.).